FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034963012> ?p ?o ?g. }

• W2034963012 endingPage "1159" @default.
• W2034963012 startingPage "1154" @default.
• W2034963012 abstract "Abstract Treatment with angiotensin-converting enzyme inhibitors increases the angiotensin-(1-7) [Ang-(1-7)] and bradykinin concentrations in plasma and tissue. In this study we evaluated the interaction between these peptides by determining the effect of Ang-(1-7) on the hypotensive action of bradykinin in conscious rats. Administration of Ang-(1-7) (5 nmol) did not change mean arterial pressure or heart rate. However, the hypotensive effect of bradykinin, produced by an intravenous or intra-arterial route, was potentiated by Ang-(1-7) in a dose-dependent manner. The Ang-(1-7) doses necessary to transform the effect of a single dose of bradykinin into that produced by a double dose (potentiating unit) were 2 nmol IV and 5 nmol IA. The Ang-(1-7) dose used did not change either the pressor effect of Ang II or the hypotensive effect of sodium nitroprusside. The bradykinin-potentiating Ang-(1-7) activity was significantly attenuated by pretreatment with indomethacin (5 mg/kg IM, n=4). In an additional group the bradykinin-potentiating activity of Ang-(1-7) was evaluated 30 minutes after treatment with the angiotensin-converting enzyme inhibitor enalaprilat (10 mg/kg IV, n=9). Under this condition the bradykinin-potentiating activity of Ang-(1-7) was substantially increased, resulting in a potentiating unit of approximately 0.2 nmol IV. Pretreatment with indomethacin (5 mg/kg IM, n=7) also attenuated the bradykinin-potentiating activity of Ang-(1-7) in enalaprilat-treated rats. These results show that Ang-(1-7) is a bradykinin-potentiating peptide in vivo. Furthermore, the data obtained with indomethacin suggest that prostaglandins participate in the mechanism of the bradykinin potentiation by Ang-(1-7). More importantly, these data suggest that the interaction between Ang-(1-7) and bradykinin can contribute to the pharmacological effects of angiotensin-converting enzyme inhibitors." @default.
• W2034963012 created "2016-06-24" @default.
• W2034963012 creator A5008125686 @default.
• W2034963012 creator A5037707557 @default.
• W2034963012 creator A5045900714 @default.
• W2034963012 creator A5089147956 @default.
• W2034963012 date "1995-12-01" @default.
• W2034963012 modified "2023-09-23" @default.
• W2034963012 title "Angiotensin-(1-7) Potentiates the Hypotensive Effect of Bradykinin in Conscious Rats" @default.
• W2034963012 cites W1504344886 @default.
• W2034963012 cites W171487091 @default.
• W2034963012 cites W1971097984 @default.
• W2034963012 cites W1987132877 @default.
• W2034963012 cites W1990632689 @default.
• W2034963012 cites W1991333067 @default.
• W2034963012 cites W1996530741 @default.
• W2034963012 cites W2005816176 @default.
• W2034963012 cites W2024086991 @default.
• W2034963012 cites W2024416570 @default.
• W2034963012 cites W2036434527 @default.
• W2034963012 cites W2038380076 @default.
• W2034963012 cites W2038970210 @default.
• W2034963012 cites W2039388069 @default.
• W2034963012 cites W2041718175 @default.
• W2034963012 cites W2055944297 @default.
• W2034963012 cites W2061430800 @default.
• W2034963012 cites W2063532711 @default.
• W2034963012 cites W2078040830 @default.
• W2034963012 cites W2079577579 @default.
• W2034963012 cites W2083030828 @default.
• W2034963012 cites W2104598696 @default.
• W2034963012 cites W2112871374 @default.
• W2034963012 cites W2121063376 @default.
• W2034963012 cites W2129523744 @default.
• W2034963012 cites W2132381842 @default.
• W2034963012 cites W2134466916 @default.
• W2034963012 cites W2145392216 @default.
• W2034963012 cites W2180931296 @default.
• W2034963012 cites W2282722486 @default.
• W2034963012 doi "https://doi.org/10.1161/01.hyp.26.6.1154" @default.
• W2034963012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7498987" @default.
• W2034963012 hasPublicationYear "1995" @default.
• W2034963012 type Work @default.
• W2034963012 sameAs 2034963012 @default.
• W2034963012 citedByCount "125" @default.
• W2034963012 countsByYear W20349630122012 @default.
• W2034963012 countsByYear W20349630122013 @default.
• W2034963012 countsByYear W20349630122014 @default.
• W2034963012 countsByYear W20349630122015 @default.
• W2034963012 countsByYear W20349630122016 @default.
• W2034963012 countsByYear W20349630122017 @default.
• W2034963012 countsByYear W20349630122018 @default.
• W2034963012 countsByYear W20349630122020 @default.
• W2034963012 countsByYear W20349630122023 @default.
• W2034963012 crossrefType "journal-article" @default.
• W2034963012 hasAuthorship W2034963012A5008125686 @default.
• W2034963012 hasAuthorship W2034963012A5037707557 @default.
• W2034963012 hasAuthorship W2034963012A5045900714 @default.
• W2034963012 hasAuthorship W2034963012A5089147956 @default.
• W2034963012 hasConcept C126322002 @default.
• W2034963012 hasConcept C134018914 @default.
• W2034963012 hasConcept C153939273 @default.
• W2034963012 hasConcept C170493617 @default.
• W2034963012 hasConcept C181199279 @default.
• W2034963012 hasConcept C185592680 @default.
• W2034963012 hasConcept C198710026 @default.
• W2034963012 hasConcept C27016395 @default.
• W2034963012 hasConcept C2776980637 @default.
• W2034963012 hasConcept C2777814262 @default.
• W2034963012 hasConcept C2779591629 @default.
• W2034963012 hasConcept C2779610285 @default.
• W2034963012 hasConcept C2779611605 @default.
• W2034963012 hasConcept C2908929049 @default.
• W2034963012 hasConcept C519581460 @default.
• W2034963012 hasConcept C55493867 @default.
• W2034963012 hasConcept C71924100 @default.
• W2034963012 hasConcept C84393581 @default.
• W2034963012 hasConcept C98274493 @default.
• W2034963012 hasConceptScore W2034963012C126322002 @default.
• W2034963012 hasConceptScore W2034963012C134018914 @default.
• W2034963012 hasConceptScore W2034963012C153939273 @default.
• W2034963012 hasConceptScore W2034963012C170493617 @default.
• W2034963012 hasConceptScore W2034963012C181199279 @default.
• W2034963012 hasConceptScore W2034963012C185592680 @default.
• W2034963012 hasConceptScore W2034963012C198710026 @default.
• W2034963012 hasConceptScore W2034963012C27016395 @default.
• W2034963012 hasConceptScore W2034963012C2776980637 @default.
• W2034963012 hasConceptScore W2034963012C2777814262 @default.
• W2034963012 hasConceptScore W2034963012C2779591629 @default.
• W2034963012 hasConceptScore W2034963012C2779610285 @default.
• W2034963012 hasConceptScore W2034963012C2779611605 @default.
• W2034963012 hasConceptScore W2034963012C2908929049 @default.
• W2034963012 hasConceptScore W2034963012C519581460 @default.
• W2034963012 hasConceptScore W2034963012C55493867 @default.
• W2034963012 hasConceptScore W2034963012C71924100 @default.
• W2034963012 hasConceptScore W2034963012C84393581 @default.
• W2034963012 hasConceptScore W2034963012C98274493 @default.
• W2034963012 hasIssue "6" @default.

• next